Subscribe

Praram 9 Hospital Public Company Limited (PR9.BK)

THB18.00 +0.60 (+3.45%)
TH SET Healthcare Medical - Care Facilities
Address 99, Rama IX Road 10310
Bangkok, TH
CEO Satian Pooprasert
Website praram9.com
IPO 2018-10-30
ISIN TH8794010000

Explore sections of this company profile

Description

Praram 9 Hospital Public Company Limited manages Praram 9 Hospital, a prominent medical institution located in Thailand. This facility delivers a broad spectrum of tertiary healthcare services, encompassing health promotion, preventative medicine, thorough diagnosis, effective treatment, and comprehensive rehabilitation. Its core medical specialties include obstetrics and gynecology, general surgery, internal medicine, pediatrics, advanced kidney transplantation, cardiovascular care, and orthopedics. The hospital further distinguishes itself with numerous specialized centers, addressing areas such as diabetes and metabolic conditions, gastroenterology and hepatobiliary issues, neurological disorders, routine health check-ups, urgent care, physical therapy and rehabilitation, advanced imaging (radiology), ophthalmology, otolaryngology (ear, nose, and throat), dentistry, mental well-being, dermatology and cosmetic procedures, breast health, joint care, spinal conditions, allergy management, oncology, sleep disorders, pulmonary and respiratory diseases, wellness programs, and LASIK eye surgery. Established in 1992, the company maintains its primary base of operations in Bangkok, Thailand.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
THB18.00 +0.60 (+3.45%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.13
Float Shares
456.41M
Free Float %
58.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+1.27% -2.44% -5.88% -23.81% -23.08% -14.44% -36.63% -9.60% +64.10% +37.93% +37.93%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
18.00
DCF (Unlevered) 50.32 +179.5%
DCF (Levered) 54.67 +203.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 2 0
Buy 11 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
8.39
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A+
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +13.8% ★ Q1'26: +3.6% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +15.4% Q1'26: -8.0% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +10.4% Q1'26: +9.0% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +17.0% ★ Q1'26: +15.9% (vs Q1'25)
  • ✓
    ROIC Medical - Care Facilities: +6.8%
    +22.7% ★ Q1'26: +19.9% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    +0.0% Q1'26: +0.0% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.02× ★ Q1'26: 0.01× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.13) × ERP
WACC = 100% × Ke + 0% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 50.32 Current price: 18.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
8 Rev. Ana.
11 EPS Ana. 		Dec 2027
11 Rev. Ana.
11 EPS Ana. 		Dec 2028
7 Rev. Ana.
7 EPS Ana. 		Dec 2029
3 Rev. Ana.
2 EPS Ana.
Revenue
2.70B
est: 2.72B (-0.6%)
2.85B
est: 2.89B (-1.4%)
2.60B
est: 2.64B (-1.4%)
2.99B
est: 2.87B (+4.2%)
4.11B
est: 4.09B (+0.4%)
4.20B
est: 4.45B (-5.5%)
4.64B
est: 4.68B (-0.9%)
5.28B
est: 5.28B (-0.1%)
5.53B
5.47B – 5.63B
+4.7% YoY
5.91B
5.48B – 6.18B
+6.9% YoY
6.27B
6.25B – 6.28B
+6.1% YoY
6.69B
6.41B – 6.91B
+6.8% YoY
EBITDA
371.54M
est: 589.09M (-36.9%)
482.07M
est: 626.25M (-23.0%)
437.78M
est: 571.86M (-23.4%)
590.25M
est: 621.26M (-5.0%)
991.29M
est: 886.64M (+11.8%)
941.45M
est: 1.02B (-7.5%)
1.17B
est: 1.07B (+9.2%)
1.21B
est: 1.21B (+0.2%)
1.27B
1.25B – 1.29B
+4.7% YoY
1.35B
1.26B – 1.41B
+6.9% YoY
1.44B
1.43B – 1.44B
+6.1% YoY
1.53B
1.47B – 1.58B
+6.8% YoY
EBIT
215.72M
est: 378.99M (-43.1%)
334.25M
est: 402.90M (-17.0%)
224.80M
est: 367.91M (-38.9%)
296.53M
est: 399.69M (-25.8%)
691.81M
est: 570.43M (+21.3%)
659.09M
est: 694.49M (-5.1%)
862.50M
est: 730.29M (+18.1%)
897.81M
est: 824.53M (+8.9%)
863.01M
853.87M – 879.21M
+4.7% YoY
922.88M
856.46M – 964.66M
+6.9% YoY
978.88M
976.33M – 981.43M
+6.1% YoY
1.05B
1.00B – 1.08B
+6.8% YoY
Net Income
157.23M
est: 240.96M (-34.8%)
284.46M
est: 298.79M (-4.8%)
202.05M
est: 198.40M (+1.8%)
249.17M
est: 188.71M (+32.0%)
567.61M
est: 561.63M (+1.1%)
557.86M
est: 626.17M (-10.9%)
712.68M
est: 711.29M (+0.2%)
822.71M
est: 822.71M (+0.0%)
855.73M
796.20M – 887.76M
+4.0% YoY
937.68M
874.56M – 1.03B
+9.6% YoY
1.03B
911.27M – 1.09B
+9.4% YoY
1.10B
1.04B – 1.14B
+7.0% YoY
SGA
541.75M
est: 505.41M (+7.2%)
569.77M
est: 537.29M (+6.0%)
518.42M
est: 490.63M (+5.7%)
557.21M
est: 533.02M (+4.5%)
735.10M
est: 760.70M (-3.4%)
773.68M
est: 816.05M (-5.2%)
837.22M
est: 858.11M (-2.4%)
987.69M
est: 968.85M (+1.9%)
1.01B
1.00B – 1.03B
+4.7% YoY
1.08B
1.01B – 1.13B
+6.9% YoY
1.15B
1.15B – 1.15B
+6.1% YoY
1.23B
1.18B – 1.27B
+6.8% YoY
EPS
0.25
est: 0.31 (-18.4%)
0.36
est: 0.38 (-5.3%)
0.26
est: 0.25 (+3.0%)
0.32
est: 0.24 (+33.3%)
0.72
est: 0.72 (+0.0%)
0.71
est: 0.80 (-10.8%)
0.91
est: 0.91 (0.0%)
1.05
est: 1.04 (+1.4%)
1.09
1.01 – 1.13
+5.5% YoY
1.22
1.11 – 1.31
+11.2% YoY
1.30
1.16 – 1.39
+7.2% YoY
1.40
1.32 – 1.46
+7.2% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-15 A+ 4/5 5/5 4/5 5/5 4/5 3/5 3/5
2026-05-14 A 4/5 5/5 4/5 5/5 4/5 2/5 3/5
2026-05-13 A+ 4/5 5/5 4/5 5/5 4/5 3/5 3/5
2026-05-12 A+ 4/5 5/5 4/5 5/5 4/5 3/5 3/5
2026-05-11 A+ 4/5 5/5 4/5 5/5 4/5 3/5 3/5
2026-05-08 A+ 4/5 5/5 4/5 5/5 4/5 3/5 3/5
2026-05-07 A+ 4/5 5/5 4/5 5/5 4/5 3/5 3/5
2026-05-06 A+ 4/5 5/5 4/5 5/5 4/5 3/5 3/5
2026-05-05 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-04-30 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-04-29 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-04-28 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-04-27 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-04-24 A 4/5 5/5 4/5 5/5 3/5 3/5 3/5
2026-04-23 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-22 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-21 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-20 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-17 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-16 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
855.03M
OE per share TTM
1.09
Owner's Yield
6.80%
Maintenance CapEx ratio
22.06%
Maint CapEx / Avg PPE
85.6%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P Emerging Markets Small Cap ETF EWX 0.02% 167.4K 0.65%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
576.3K
Shares Outstanding
786.30M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Satian Pooprasert Vice Chairman, MD & Chief Executive Officer 150.0K —
Viroon Mavichak Senior Deputy MD & Director 150.0K —
Prasert Trairatvorakul Deputy MD of Nursing and Medical Service Department & Director 150.0K —
North Techawathanawanna Deputy Managing Director of Medical & Human Resources — —
Sasivimon Suksai Chief of Internal Audit — female
Duangkamol Wongsaita Chief Accountant — female
Wittaya Wanpen Deputy Managing Director of Business Development & Strategy Office — —
Kamaporn Tumpipit CFO, Head of investor relations and Deputy MD of Accounting & Finance Department — female
Marisara Thanasaksiri Company Secretary & Head of Compliance — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities